Publicado: Пт, Ноября 23, 2018
Salud | Por Gertrudes Rodriquez

Insulin shortage puts millions at risk, study shows

Insulin shortage puts millions at risk, study shows

The US study team believe this increase could lead to an insulin shortage for people with type 2 diabetes unless access to the hormone is significantly improved.

The estimates suggest that making insulin widely accessible in Asia could more than double numbers of insulin users from 21 million to 48 million people. Untreated diabetes could lead to heart and kidney diseases, blindness, amputation, and stroke. Among the findings was a projected 20 percent rise in total type 2 diabetes sufferers, from 406 million in 2018 to 511 million in 2030.

A few months ago, another study conducted by researchers at the University of Colorado had revealed that methyldopa, a common drug used to treat hypertension could prevent the onset of type 1 diabetes. Also, the expensive treatment is dominated by three manufacturers.

Editor's note: Eating a healthy diet low in carbohydrate, sugar and processed food can help to lower blood glucose levels, and people with type 2 diabetes have been able to put the condition into remission, coming off all their diabetes medication, by following a healthy eating plan.

Insulin use is expected to rise 20 percent by 2030, and many people who need it for type 2 diabetes won't have access, a study from Stanford University suggests. The study found that the rise in the number of people affected by the disease is likely to rise by around 20 per cent over the people affected now.

Читайте также: Trump says he might attend White House Correspondents Dinner

The figures were presented in a study published on Wednesday in the journal Lancet Diabetes and Endocrinology. At the same time, global insulin use is projected to rise from 526 million 1000-unit vials in 2018 to 634 million in 2030.

"Despite the UN's commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily hard for patients to access".

Sanjay Basu also added that governments should begin effective initiatives to make insulin affordable for patients all across the world.

"Despite the U.N.'s commitment to treat noncommunicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily hard for patients to access". In May, William T. Cefalu, the chief scientific, medical and mission officer with the American Diabetes Association, testified before Senate to discussing insulin price, which have tripled between 2002 and 2013.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2019 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Me gusta esto: